<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39497076</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>05</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Long COVID and recovery from Long COVID: quality of life impairments and subjective cognitive decline at a median of 2&#xa0;years after initial infection.</ArticleTitle><Pagination><StartPage>1241</StartPage><MedlinePgn>1241</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1241</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-10158-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Recovery from SARS CoV-2 infection is expected within 3&#xa0;months. Long COVID occurs after SARS-CoV-2 when symptoms are present for more than 3&#xa0;months that are continuous, relapsing and remitting, or progressive. Better understanding of Long COVID illness trajectories could strengthen patient care and support.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We characterized functional impairments, quality of life (QoL), and cognition among patients who recovered from SARS-CoV-2 infection within 3&#xa0;months (without Long COVID), after 3&#xa0;months (Recovered Long COVID), or remained symptomatic (Long COVID). Among 7305 patients identified with previous SARS-CoV-2 infection between March 2020 and December 2021, confirmed in the medical record with laboratory test or physician diagnosis, 435 (6%) completed a single self-administered survey between March 2022 and September 2022. Multi-domain QoL and cognitive concerns were evaluated using PROMIS-29 and the Cognitive Change Index-12.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nearly half the participants (47.7%) were surveyed more than 2&#xa0;years from initial infection (median&#x2009;=&#x2009;23.3&#xa0;months; IQR&#x2009;=&#x2009;18.6, 26.7) and 86.7% were surveyed more than 1&#xa0;year from infection. A significantly greater proportion of the Long COVID (n&#x2009;=&#x2009;215) group, (Current and Recovered combined), had moderate-to-severe impairment in all health domains assessed compared to those Without Long COVID (n&#x2009;=&#x2009;220; all p&#x2009;&lt;&#x2009;0.05). The Recovered Long COVID group (n&#x2009;=&#x2009;34) had significantly lower prevalence of fatigue, pain, depression, and physical and social function impairment compared to those with Current Long COVID (n&#x2009;=&#x2009;181; all p&#x2009;&lt;&#x2009;0.05). However, compared to patients Without Long COVID, the Recovered Long COVID group had greater prevalences of fatigue, pain (p&#x2009;&#x2264;&#x2009;0.06) and subjective cognitive decline (61.8% vs 29.1%; p&#x2009;&lt;&#x2009;0.01). Multivariate relative risk (RR) regression indicated Long COVID risk was greater for older age groups (RR range 1.46-1.52; all p&#x2009;&#x2264;&#x2009;0.05), those without a bachelor's degree (RR&#x2009;=&#x2009;1.33; 95% CI&#x2009;=&#x2009;1.03-1.71; p&#x2009;=&#x2009;0.03), and those with 3 or more comorbidities prior to SARS-CoV-2 infection (RR&#x2009;=&#x2009;1.45; 95% CI&#x2009;=&#x2009;1.11-1.90; p&#x2009;&lt;&#x2009;0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Long COVID is associated with long-term subjective cognitive decline and diminished quality of life. Clinically significant cognitive complaints, fatigue, and pain were present even in those who reported they had recovered from Long COVID. These findings have implications for the sustainability of participation in work, education, and social activities.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Szewczyk</LastName><ForeName>Warren</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. warrenjs@uw.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fitzpatrick</LastName><ForeName>Annette L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fossou</LastName><ForeName>Herve</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gentile</LastName><ForeName>Nicole L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sotoodehnia</LastName><ForeName>Nona</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Cardiovascular Health Research Unit, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vora</LastName><ForeName>Surabhi B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Seattle Children's Hospital, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>West</LastName><ForeName>T Eoin</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertolli</LastName><ForeName>Jeanne</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cope</LastName><ForeName>Jennifer R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jin-Mann S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Unger</LastName><ForeName>Elizabeth R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vu</LastName><ForeName>Quan M</ForeName><Initials>QM</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cognition</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID condition</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Recovery</Keyword><Keyword MajorTopicYN="N">Subjective cognitive decline</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>23</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39497076</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-10158-w</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-10158-w</ArticleId><ArticleId IdType="pmc">PMC11536968</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Post COVID-19 condition (Long COVID). Available from: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition. Cited 2023 Jul 17.</Citation></Reference><Reference><Citation>Hirschtick JL, Titus AR, Slocum E, Power LE, Hirschtick RE, Elliott MR, et al. Population-based estimates of post-acute sequelae of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection (PASC) prevalence and characteristics. Clin Infect Dis. 2021;73(11):2055&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8240848</ArticleId><ArticleId IdType="pubmed">34007978</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;46. Available from: https://www.nature.com/articles/s41579-022-00846-2. Cited 2023 Aug 18.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657&#x2013;66.&#xa0;Available from: https://linkinghub.elsevier.com/retrieve/pii/S1198743X22000386. Cited 2023 Jan 30.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Bae S, Chang HH, Kim SW. Long COVID prevalence and impact on quality of life 2 years after acute COVID-19. Sci Rep. 2023;13(1):11207.&#xa0;Available from: https://pubmed.ncbi.nlm.nih.gov/37433819/. Cited 2023 Jul 29.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10336045</ArticleId><ArticleId IdType="pubmed">37433819</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28(11):2406&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Imoto W, Yamada K, Kawai R, Imai T, Kawamoto K, Uji M, et al. A cross-sectional, multicenter survey of the prevalence and risk factors for Long COVID. Sci Rep. 2022;12(1):1&#x2013;10.&#xa0;Available from: https://www.nature.com/articles/s41598-022-25398-6. Cited 2023 Aug 18.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9793373</ArticleId><ArticleId IdType="pubmed">36575200</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JH, Womack KN, Tenforde MW, Files DC, Gibbs KW, Shapiro NI, et al. Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress. Influenza Other Respir Viruses. 2022;16(4):680&#x2013;9.&#xa0;Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/irv.12980. Cited 2023 Aug 18.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12980</ArticleId><ArticleId IdType="pmc">PMC9111447</ArticleId><ArticleId IdType="pubmed">35347854</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N, Zhao YM, Yan W, Li C, Lu QD, Liu L, et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry. 2023;28(1):423&#x2013;33. Available from: https://pubmed.ncbi.nlm.nih.gov/35668159. Cited 2023 Aug 18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali ST, Kang AK, Patel TR, Clark JR, Perez-Giraldo GS, Orban ZS, et al. Evolution of neurologic symptoms in non-hospitalized COVID-19 &#x201c;long haulers.&#x201d; Ann Clin Transl Neurol. 2022;9(7):950&#x2013;61.&#xa0;Available from: https://pubmed.ncbi.nlm.nih.gov/35607826/. Cited 2023 Aug 18.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9268866</ArticleId><ArticleId IdType="pubmed">35607826</ArticleId></ArticleIdList></Reference><Reference><Citation>Fineberg HV, Brown L, Worku T, Goldowitz I, editors. A Long COVID Definition. Washington: National Academies Press; 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">39110819</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M, Udeh R, Yon DK, Lee SW, Dolja-Gore X, McEVoy M, et al. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: a call to action for neurological, physical, and psychological sciences. J Med Virol. 2023;95(6):e28852.</Citation><ArticleIdList><ArticleId IdType="pubmed">37288652</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira Almeida K, Nogueira Alves IG, de Queiroz RS, de Castro MR, Gomes VA, Santos Fontoura FC, et al. A systematic review on physical function, activities of daily living and health-related quality of life in COVID-19 survivors. Chronic Illn. 2023;19(2):279&#x2013;303.&#xa0;Available from: http://journals.sagepub.com/doi/10.1177/17423953221089309. Cited 2023 Aug 20.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17423953221089309</ArticleId><ArticleId IdType="pmc">PMC9006095</ArticleId><ArticleId IdType="pubmed">35404175</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;A systematic review and meta-analysis. J Med Virol. 2022;94(1):253. Available from: /pmc/articles/PMC8662132/. Cited 2023 Aug 18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker S, Goodfellow H, Pookarnjanamorakot P, Murray E, Bindman J, Blandford A, et al. Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study. BMJ Open. 2023;13(6):e069217.&#xa0;Available from: https://bmjopen.bmj.com/content/13/6/e069217. Cited 2023 Aug 18.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10335413</ArticleId><ArticleId IdType="pubmed">37286327</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat Med. 2023;29(9):2347&#x2013;57.&#xa0;Available from: https://www.nature.com/articles/s41591-023-02521-2.&#xa0;
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, Chen Y, Wang QH, Wang LR, Jiang L, Yang Y, et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol. 2022;79(5):509&#x2013;17.&#xa0;Available from: https://jamanetwork.com/journals/jamaneurology/fullarticle/2789919. Cited 2023 Mar 19.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu TC, Yoo SM, Sim MS, Motwani Y, Viswanathan N, Wenger NS. Perceived cognitive deficits in patients with symptomatic SARS-CoV-2 and their association with Post&#x2013;COVID-19 condition. JAMA Netw Open. 2023;6(5): e2311974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715897</ArticleId><ArticleId IdType="pubmed">37145596</ArticleId></ArticleIdList></Reference><Reference><Citation>Risacher SL, Deardorff R, Saykin AJ. Subjective vs. objective memory predictors of AD biomarkers and future cognitive, clinical, and functional decline. Alzheimer&#x2019;s Dement. 2022;18(S7):e068041 https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.068041. Cited 2023 Aug 18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.068041</ArticleId></ArticleIdList></Reference><Reference><Citation>Slot RER, Sikkes SAM, Berkhof J, Brodaty H, Buckley R, Cavedo E, et al. Subjective cognitive decline and rates of incident Alzheimer&#x2019;s disease and non&#x2013;Alzheimer&#x2019;s disease dementia. Alzheimers Dement. 2019;15(3):465&#x2013;76. Available from:&#xa0;https://onlinelibrary.wiley.com/doi/full/10.1016/j.jalz.2018.10.003. Cited 2023 Aug 18.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.10.003</ArticleId><ArticleId IdType="pmc">PMC6465066</ArticleId><ArticleId IdType="pubmed">30555032</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell AJ, Beaumont H, Ferguson D, Yadegarfar M, Stubbs B. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: Meta-analysis. Acta Psychiatr Scand. 2014;130(6):439&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">25219393</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins A, Tree JJ, Thornton IM, Tales A. Subjective cognitive impairment in 55&#x2013;65-year-old adults is associated with negative affective symptoms, neuroticism, and poor quality of life. J Alzheimers Dis. 2019;67(4):1367&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6398551</ArticleId><ArticleId IdType="pubmed">30689577</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike KE, Cavuoto MG, Li L, Wright BJ, Kinsella GJ. Subjective cognitive decline: level of risk for future dementia and mild cognitive impairment, a meta-analysis of longitudinal studies. Neuropsychol Rev. 2022;32(4):703&#x2013;35.&#xa0;Available from: https://link.springer.com/10.1007/s11065-021-09522-3.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-021-09522-3</ArticleId><ArticleId IdType="pubmed">34748154</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Blanco L, Felpete A, Patten SB, Mallo SC, Pereiro AX, Campos-Magdaleno M, et al. Do informant-reported subjective cognitive complaints predict progression to mild cognitive impairment and dementia better than self-reported complaints in old adults?&#xa0;A meta-analytical study. Ageing Res Rev. 2022;82:101772.&#xa0;Available from: https://linkinghub.elsevier.com/retrieve/pii/S1568163722002148.
</Citation><ArticleIdList><ArticleId IdType="pubmed">36374732</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill NL, McDermott C, Mogle J, Munoz E, DePasquale N, Wion R, et al. Subjective cognitive impairment and quality of life: a systematic review. Int Psychogeriatr. 2017;29(12):1965&#x2013;77.&#xa0; Available from: https://www.cambridge.org/core/product/identifier/S1041610217001636/type/journal_article.
</Citation><ArticleIdList><ArticleId IdType="pubmed">28829003</ArticleId></ArticleIdList></Reference><Reference><Citation>Stickel AM, Tarraf W, Wu B, Marquine MJ, V&#xe1;squez PM, Daviglus M, et al. Cognition and Daily Functioning: Results from the Hispanic Community Health Study/Study of Latinos (SOL) and Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA). J Alzheimers Dis. 2020;77(3):1267&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7945678</ArticleId><ArticleId IdType="pubmed">32831203</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, Zhang H, Ren LL, Guo L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):863&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, et al. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. 2022;14(12):2629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford ND, Slaughter D, Edwards D, Dalton A, Perrine C, Vahratian A, et al. Long COVID and significant activity limitation among adults, by age &#x2014; United States, June 1&#x2013;13, 2022, to June 7&#x2013;19, 2023. Morb Mortal Wkly Rep. 2023;72(32):866&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId></ArticleIdList></Reference><Reference><Citation>Symptoms of COVID-19 | CDC. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html. Cited 2023 Jul 17.</Citation></Reference><Reference><Citation>Hays RD, Spritzer KL, Schalet BD, Cella D. PROMIS&#xae;-29 v2.0 profile physical and mental health summary scores. Qual Life Res. 2018;27(7):1885 Available from: /pmc/articles/PMC5999556/. Cited 2023 Jul 17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5999556</ArticleId><ArticleId IdType="pubmed">29569016</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella D, Choi SW, Condon DM, Schalet B, Hays RD, Rothrock NE, et al. PROMIS&#xae; adult health profiles: efficient short-form measures of seven health domains. Value in Health. 2019;22(5):537&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201383</ArticleId><ArticleId IdType="pubmed">31104731</ArticleId></ArticleIdList></Reference><Reference><Citation>Rattanabannakit C, Risacher SL, Gao S, Lane KA, Brown SA, McDonald BC, et al. The cognitive change index as a measure of self and informant perception of cognitive decline: relation to neuropsychological tests. J Alzheimers Dis. 2016;51(4):1145&#x2013;55.&#xa0;Available from: http://www.adni-info.org. Cited 2023 Aug 18.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4833578</ArticleId><ArticleId IdType="pubmed">26923008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ader DN. Developing the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care. 2007;45(5):S1-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2829758</ArticleId><ArticleId IdType="pubmed">17443116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevans M, Ross A, Cella D. Patient-Reported Outcomes Measurement Information System (PROMIS): Efficient, standardized tools to measure self-reported health and quality of life. Nurs Outlook. 2014;62(5):339&#x2013;45.&#xa0;Available from: https://linkinghub.elsevier.com/retrieve/pii/S0029655414001067.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4179871</ArticleId><ArticleId IdType="pubmed">25015409</ArticleId></ArticleIdList></Reference><Reference><Citation>Risacher SL, Kim S, Nho K, Foroud T, Shen L, Petersen RC, et al. APOE effect on Alzheimer&#x2019;s disease biomarkers in older adults with significant memory concern. Alzheimers Dement. 2015;11(12):1417&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4637003</ArticleId><ArticleId IdType="pubmed">25960448</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou G. A Modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15033648</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenland S. Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol. 2004;160(4):301&#x2013;5.&#xa0;Available from: https://academic.oup.com/aje/article-lookup/doi/10.1093/aje/kwh221.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwh221</ArticleId><ArticleId IdType="pubmed">15286014</ArticleId></ArticleIdList></Reference><Reference><Citation>Samper-Pardo M, Oliv&#xe1;n-Bl&#xe1;zquez B, Magall&#xf3;n-Botaya R, M&#xe9;ndez-L&#xf3;pez F, Bartolom&#xe9;-Moreno C, Le&#xf3;n-Herrera S. The emotional well-being of Long COVID patients in relation to their symptoms, social support and stigmatization in social and health services: a qualitative study. BMC Psychiatry. 2023;23(1):68.&#xa0;Available from: https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-022-04497-8.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-022-04497-8</ArticleId><ArticleId IdType="pmc">PMC9875186</ArticleId><ArticleId IdType="pubmed">36698111</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi N V., Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434. Available from: https://pubmed.ncbi.nlm.nih.gov/35121209/. Cited 2023 Aug 18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivari BS, Baumgart M, Taylor CA, McGuire LC. Population measures of subjective cognitive decline: a means of advancing public health policy to address cognitive health. Alzheimers Dement. 2021;7(1):e12142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919133</ArticleId><ArticleId IdType="pubmed">33681450</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;hr S, Pabst A, Riedel-Heller SG, Jessen F, Turana Y, Handajani YS, et al. Estimating prevalence of subjective cognitive decline in and across international cohort studies of aging: a COSMIC study. Alzheimers Res Ther. 2020;12(1):167. Available from:&#xa0;https://alzres.biomedcentral.com/articles/10.1186/s13195-020-00734-y.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00734-y</ArticleId><ArticleId IdType="pmc">PMC7749505</ArticleId><ArticleId IdType="pubmed">33339532</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39: 101044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Lunz Trujillo K, Safarpour A, Santillana M, Ognyanova K, Druckman J, et al. Association of Post&#x2013;COVID-19 condition symptoms and employment status. JAMA Netw Open. 2023;6(2):e2256152&#x2013;e2256152.&#xa0;Available from: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801458. Cited 2023 Aug 18.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9932847</ArticleId><ArticleId IdType="pubmed">36790806</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention, National Center for Health Statistics, U.S. Census Bureau. Long COVID. Household Pulse Survey, 2022&#x2013;2024. 2024.</Citation></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, Safarpour A, Lunz Trujillo K, Simonson MD, et al. Prevalence and Correlates of Long COVID Symptoms Among US Adults. JAMA Netw Open. 2022;5(10):E2238804.&#xa0;Available from: https://pubmed.ncbi.nlm.nih.gov/36301542/. Cited 2023 Feb 10.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolla SA, Sullivan J. Education, income, and wealth. page one economics. Federal Reserve Bank of St. Louis; 2017. Available from: https://www.stlouisfed.org/publications/page-one-economics/2017/01/03/education-income-and-wealth. Cited 2024 Sep 13.</Citation></Reference><Reference><Citation>Clouston SAP, Link BG. A retrospective on fundamental cause theory: state of the literature and goals for the future. Annu Rev Sociol. 2021;47(1):131&#x2013;56. Available from:&#xa0;https://www.annualreviews.org/doi/10.1146/annurev-soc-090320-094912.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-soc-090320-094912</ArticleId><ArticleId IdType="pmc">PMC8691558</ArticleId><ArticleId IdType="pubmed">34949900</ArticleId></ArticleIdList></Reference><Reference><Citation>Karpman M, Zuckerman S, Morriss S. Health care access and affordability among US adults aged 18 to 64 years with self-reported Post&#x2013;COVID-19 condition. JAMA Netw Open. 2023;6(4): e237455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10087049</ArticleId><ArticleId IdType="pubmed">37036705</ArticleId></ArticleIdList></Reference><Reference><Citation>Ham D. Long-haulers and labor market outcomes. 2022. (Institute Working Paper). Report No.: 60. Available from: https://www.minneapolisfed.org/research/institute-working-papers/long-haulers-and-labor-market-outcomes. Cited 2024 Sep 13.</Citation></Reference><Reference><Citation>Bergmans RS, Chambers-Peeple K, Yu C, Xiao LZ, Wegryn-Jones R, Martin A, et al. &#x2018;I&#x2019;m still here, I&#x2019;m alive and breathing&#x2019;: The experience of Black Americans with long COVID. J Clin Nurs. 2024;33(1):162&#x2013;77. Available from:&#xa0;https://onlinelibrary.wiley.com/doi/10.1111/jocn.16733.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.16733</ArticleId><ArticleId IdType="pmc">PMC10624641</ArticleId><ArticleId IdType="pubmed">37140186</ArticleId></ArticleIdList></Reference><Reference><Citation>Crenshaw K. Demarginalizing the intersection of race and sex: a black feminist critique of antidiscrimination doctrine, feminist theory and antiracist politics. University of Chicago Legal Forum. 1989;1989(1).</Citation></Reference><Reference><Citation>Bowleg L. The problem with the phrase women and minorities: intersectionality&#x2014;an important theoretical framework for public health. Am J Public Health. 2012;102(7):1267&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3477987</ArticleId><ArticleId IdType="pubmed">22594719</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter MKA, McGill LS, Aaron RV, Hosey MM, Keatley E, Sanchez Gonzalez ML. We still cannot breathe: applying intersectional ecological model to COVID-19 survivorship. Rehabil Psychol. 2023;68(2):112&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">37166940</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. Available from: https://covid19.who.int/. Cited 2023 Feb 9.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>